Volume 21, Number 7—July 2015
Research
Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia
Table 3
Mutation analysis of candidate therapeutic drug and diagnostic binding sites for EBOV*
Reference position | Type | Reference base | Called base | EBOV-WA, % | EBOV-LIB, % | Codon | Feature name |
---|---|---|---|---|---|---|---|
850 | SNP | A | G | 100 | 100 | G:GGA @ 127 → G:GGg | NP |
852 | SNP | A | G | 100 | 100 | K:AAA @ 128 → R:AgA | NP |
895 | SNP | A | G | 100 | 100 | T:ACA @ 142 → T:ACg | NP |
907 | SNP | T | C | 1 | 0 | N:AAT @ 146 → N:AAc | NP |
919 | SNP | T | C | 100 | 100 | F:TTT @ 150 → F:TTc | NP |
1288 | SNP | A | T | 1 | 0 | V:GTA @ 273 → V:GTt | NP |
1495 | SNP | A | G | 100 | 100 | Q:CAA @ 342 → Q:CAg | NP |
1498 | SNP | C | T | 1 | 4 | L:CTC @ 343 → L:CTt | NP |
1507 | SNP | T | A | 100 | 100 | A:GCT @ 346 → A:GCa | NP |
1552 | SNP | C | T | 100 | 100 | R:CGC @ 361 → R:CGt | NP |
1862 | SNP | A | G | 100 | 100 | S:AGC @ 465 → G:gGC | NP |
6359 | SNP | T | C | 100 | 100 | N:AAT @ 107 → N:AAc | GP |
6909 | SNP | T | A | 1 | 0 | W:TGG @ 291 → R:aGG | GP |
7730 | SNP | G | A | 100 | 100 | E:GAG @ 564 → E:GAa | GP |
7775 | SNP | A | G | 100 | 100 | L:CTA @ 579 → L:CTg | GP |
7778 | SNP | C | A | 100 | 100 | R:CGC @ 580 → R:CGa | GP |
10252 | SNP | A | T | 1 | 4 | ||
10253 | SNP | A | G | 1 | 0 | ||
12694 | SNP | T | A | 100 | 100 | I:ATT @ 371 → I:ATa | L |
12886 | SNP | A | C | 2 | 0 | L:CTA @ 435 → L:CTc | L |
12952 | SNP | A | G | 100 | 100 | L:CTA @ 457 → L:CTg | L |
13267 | SNP | C | T | 100 | 100 | T:ACC @ 562 → T:ACt | L |
13607 | SNP | G | A | 1 | 4 | V:GTC @ 676 → I:aTC | L |
13624 | SNP | T | G | 1 | 0 | N:AAT @ 681 → K:AAg | L |
13630 | SNP | A | G | 100 | 100 | P:CCA @ 683 → P:CCg | L |
*EBOV, Ebola virus; GP; glycoprotein, ; L, RNA-dependent RNA polymerase; LIB, Liberia; NP; nucleoprotein; SNP, single-nucleotide polymorphism; WA, Western Africa.
1These authors contributed equally to this article.